AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15307288
Drug: Magnetostimulation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetostimulation with weak variable magnetic field (15 microT) for 12 minutes daily for 15 days added to pharmacological therapy.
Trial: 11713611
Drug: Buspirone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (0.5 mg x kg bw(‐1) orally)
Trial: 11713611
Drug: Buspirone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone with pindolol pre‐treatment (40 mg over 2 days, 0.5 mg x kg bw(‐1) on test day)
Trial: 11713611
Drug: Pindolol alone
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol alone (40 mg over 2 days)
Trial: 11713611
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with pindolol pre‐treatment
Trial: 24622804
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (2000 IU oral vitamin D3/d)
Trial: 20083429
Drug: Standard CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard CPAP titration during polysomnography (PSG)
Trial: 20083429
Drug: Ambulatory titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambulatory titration using auto‐CPAP and home sleep testing
Trial: 18812608
Drug: BI 1356
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 1356 (2.5 mg)
Trial: 18812608
Drug: BI 1356
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 1356 (5 mg)
Trial: 18812608
Drug: BI 1356
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 1356 (100 mg to 600 mg)
Trial: 18812608
Drug: BI 1356
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 1356 (600 mg)
Trial: 6423016
Drug: Capsaicin inhalation
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin inhalation (2-65 mumol l(-1), 1 min duration)
Trial: 810270
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate inhalation
Trial: 20810517
Drug: Treatment arms
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment arms
Trial: 25462877
Drug: Enhanced cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced cognitive behavior therapy (CBT-E)
Trial: 23270535
Drug: Exercise intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exercise intervention (two different doses)
Trial: 6403323
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg ergotamine tartrate
Trial: 6403323
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg ergotamine tartrate
Trial: 24836213
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg daily for three months
Trial: 18418029
Drug: Desloratadine (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine (standard dose) during association phase
Trial: 18418029
Drug: Novel-tasting drink
RxNorm normalized name: 60 Second Taste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel-tasting drink with placebo pill (CS group) during evocation trial
Trial: 18418029
Drug: Water with
RxNorm normalized name: sterile water with electrolytes injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water with desloratadine (drug group) during evocation trial
Trial: 12888045
Drug: Topical betaxolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical betaxolol (twice daily)
Trial: 8917061
Drug: Remacemide hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
DrugBank: Remacemide (DB06458)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remacemide hydrochloride 300 mg twice daily for 14 days
Trial: 1869343
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg diphenhydramine
Trial: 26998485
Drug: Fractional CO2
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO2 laser plus topical application of Botulinum Toxin Type A (BTX‐A)
Trial: 26998485
Drug: Fractional CO2
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO2 plus saline solution
Trial: 26998485
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (BTX‐A and saline solution)
Trial: 17413119
Drug: 10.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.5 g P. ovata husk/d
Trial: 17413119
Drug: 10.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.5 g P. ovata seeds/d
Trial: 12882179
Drug: Weights over
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weights over 1,500 g
Trial: 12882179
Drug: Weights <
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weights < 1,500 g
Trial: 7588510
Drug: High-fibre diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fibre diet based on oat bran (31.9 g/day fibre)
Trial: 7588510
Drug: Low-fibre diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fibre diet based on wheat flour (7.8 g/day fibre)
Trial: 6999828
Drug: Ketocaine compresses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketocaine compresses (1 g ketocaine in a 10% ethanol solution)
Trial: 25742716
Drug: Standard-dose GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose GH treatment (33 μg kg(‐1) day(‐1))
Trial: 25742716
Drug: Double-dose treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose treatment (67 μg kg(‐1) day(‐1))
Trial: 19798097
Drug: Diuretics as
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics as component of therapy
Trial: 19798097
Drug: Renin system
RxNorm normalized name: Benzoin resin
DrugBank: Benzoin resin (DB11222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renin system inhibitors
Trial: 16117967
Drug: CQ +
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CQ + AS (4 mg/kg bodyweight daily for 3 days)
Trial: 16117967
Drug: CQ (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CQ (25 mg/kg bodyweight over 3 days)
Trial: 10836728
Drug: Manidipine (M)
RxNorm normalized name: manidipine
DrugBank: Manidipine (DB09238)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine (M) 10-20 mg, od, for 24 weeks
Trial: 10836728
Drug: Enalapril (E)
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril (E) 10-20 mg, od, for 24 weeks
Trial: 9376779
Drug: bromocriptine 25
RxNorm normalized name: bromocriptine 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromocriptine 25 mg
Trial: 9376779
Drug: bromocriptine 50
RxNorm normalized name: bromocriptine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromocriptine 50 mg
Trial: 1317178
Drug: Scopolamine (0.002,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine (0.002, 0.004, and 0.007 mg/kg)
Trial: 1317178
Drug: Intramuscular glycopyrrolate
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular glycopyrrolate (0.0044 mg/kg)
Trial: 3910428
Drug: Droperidol 2.5
RxNorm normalized name: droperidol 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 2.5 mg i.m. before anaesthesia
Trial: 3910428
Drug: Droperidol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 1.25 mg i.v. at the end of anaesthesia
Trial: 30201408
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg BMS-986020 (bid)
Trial: 30201408
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg BMS-986020 (qd)
Trial: 27139158
Drug: Pregabalin 450
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 450 mg/d
Trial: 25985851
Drug: Placebo (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (one capsule of placebo per day)
Trial: 21600390
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug (generic Mycophenolate mofetil 500 mg)
Trial: 21600390
Drug: Reference drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference drug (branded Mycophenolate mofetil 500 mg)
Trial: 19713965
Drug: Telmisartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40 mg daily)
Trial: 16449345
Drug: SR 49059
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR 49059 (200 mg once daily)
Trial: 15033935
Drug: Oral tertatolol
RxNorm normalized name: tertatolol
DrugBank: Tertatolol (DB13775)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tertatolol (nonselective beta-antagonist) treatment during exercise bouts at 35% and 60% peak oxygen consumption (VO2max)
Trial: 15033935
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment during exercise bouts at 35% and 60% peak oxygen consumption (VO2max)
Trial: 11284814
Drug: Sevoflurane in
RxNorm normalized name: sevoflurane Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane in nitrous oxide-oxygen (2 : 1 l.min‐1)
Trial: 11284814
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl 1 microg.kg‐1 + propofol 2 mg.kg‐1 followed by nitrous oxide-oxygen (2 : 1 l.min‐1) and sevoflurane
Trial: 11284814
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl + propofol
Trial: 9307536
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of prostaglandin E2 2 mg vaginal gel
Trial: 9307537
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of prostaglandin E2 (2 mg each, second dose after six hours if needed)
Trial: 9307537
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of prostaglandin E2 (2 mg each)
Trial: 8025745
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP), 500 micrograms twice per day
Trial: 17196292
Drug: Pulsed Electromagnetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed Electromagnetic Field (PEMF) therapy
Trial: 28777127
Drug: Individualized vibrotactile
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized vibrotactile neurofeedback training (IVNT) combined with oral medication (20 mg cinnarizine and 40 mg dimenhydrinate, three tablets per day)
Trial: 26399571
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioural therapy (iCBT)
Trial: 26399571
Drug: Weekly check-in
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly check-in control group
Trial: 25044795
Drug: Food formulations
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food formulations with unsaturated/saturated fat and beetroot extract
Trial: 9058311
Drug: Subcutaneous interferon-beta
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous interferon-beta (IFN-beta) 6 million units, three times per week for 6 months
Trial: 8215790
Drug: Perindopril 1
RxNorm normalized name: AMLODIPINE 10MG/PERINDOPRIL 14MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 1 mg/Kg/day for 5 months
Trial: 3525237
Drug: Testosterone cypionate
RxNorm normalized name: Testosterone Cypionate
DrugBank: Testosterone cypionate (DB13943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone cypionate (TC) 200 mg intramuscularly every 14 days for six injections
Trial: 27084653
Drug: Intensity Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity Modulated Proton Therapy (IMPT)
Trial: 27354125
Drug: Intensity Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity Modulated Photon Therapy (IMRT)
Trial: 20427546
Drug: Piperacillin-tazobactam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam (4 x 4.5 g IV/day)
Trial: 20427546
Drug: Carbapenem (meropenem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbapenem (meropenem 3 x 1 g IV/day or imipenem 4 x 500 mg IV/day) with or without amikacin (1 g IV/day)
Trial: 19667717
Drug: COX-2 selective
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: COX-2 selective inhibitors (general)
Trial: 12891643
Drug: Galantamine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (16 mg per day)
Trial: 12891643
Drug: Galantamine (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (24 mg per day)
Trial: 12891643
Drug: No cholinesterase
RxNorm normalized name: cholinesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No cholinesterase therapy (control)
Trial: 8768828
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg MK-677
Trial: 8768828
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg MK-677
Trial: 8332270
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Propranolol and Nifedipine
Trial: 3298404
Drug: Acyclovir, 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir, 45 mg/kg/day by continuous intravenous infusion for 28 days
Trial: 29663857
Drug: Brain training
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brain training program with weekly supervision (600 min playtime)
Trial: 29663857
Drug: Passive intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Passive intervention with supervision twice (offered after trial)
Trial: 27716229
Drug: Ropivacaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (20 mL of 0.375%)
Trial: 27716229
Drug: Ropivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine with betamethasone (19 mL of 0.375% ropivacaine + 4 mg betamethasone)
Trial: 24300220
Drug: Indomethacin submicron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin submicron particle capsules 20 mg
Trial: 24300220
Drug: Indomethacin submicron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin submicron particle capsules 40 mg
Trial: 20195587
Drug: Chiral method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiral method (S-ibuprofen)
Trial: 20195587
Drug: Chiral method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiral method (R-ibuprofen)
Trial: 18054932
Drug: Cetrorelix (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetrorelix (0.25 mg)
Trial: 10835489
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 50 mg/day
Trial: 8708495
Drug: Procaterol delivered
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol delivered by metered-dose inhaler (MDI) with paper spacer
Trial: 8708495
Drug: Procaterol delivered
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol delivered by metered-dose inhaler (MDI) without spacer
Trial: 1928683
Drug: Propofol anaesthetic
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol anaesthetic using infusion technique
Trial: 7133972
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of pirprofen
Trial: 7133972
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg of pirprofen
Trial: 31912958
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose carbon monoxide inhalation (1.2 ml/kg for men; 1.0 ml/kg for women)
Trial: 28257388
Drug: Single-shot ultrasound-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-shot ultrasound-guided SSNB (10 mL ropivacaine 1%)
Trial: 28257388
Drug: Interscalene brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interscalene brachial plexus block (ISB) (20 mL ropivacaine 0.75%)
Trial: 25157767
Drug: Pemetrexed (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed (500 mg/m), Carboplatin (AUC 6), Bevacizumab (15 mg/kg) administered on day 1 of each 21-day cycle for up to six cycles, followed by maintenance pemetrexed and bevacizumab.
Trial: 15044641
Drug: Dexamethasone (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.25 mg/kg IV every 12 hours for one week, then tapered)
Trial: 11370826
Drug: OND 32
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OND 32 mg for the first 24 hours, followed by 8 mg every 8 hours for the following four days, combined with dexamethasone 8 mg i.v. the first day and 8 mg p.o. for the following three days.
Trial: 11370826
Drug: OND 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OND 8 mg every day for 4 days, combined with dexamethasone 8 mg i.v. and 8 mg p.o. for the following three days.
Trial: 7798429
Drug: Tetracycline 500
RxNorm normalized name: oxytetracycline 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline 500 mg, taken twice daily for 3 months
Trial: 7798429
Drug: Tab. Gugulipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tab. Gugulipid (equivalent to 25 mg guggulsterone), taken twice daily for 3 months
Trial: 3201130
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml antacid
Trial: 28742529
Drug: Empiric tuberculosis
RxNorm normalized name: Mycobacterium tuberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric tuberculosis therapy
Trial: 28742529
Drug: Preventive tuberculosis
RxNorm normalized name: Mycobacterium tuberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive tuberculosis therapy
Trial: 18972914
Drug: Preoperative kinesic
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative kinesic treatment (K)
Trial: 16554988
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg per hour SiV for 4 days
Trial: 7607582
Drug: Heparin‐induced extracorporeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin‐induced extracorporeal LDL precipitation (HELP)
Trial: 1555059
Drug: Calcium (1.5
RxNorm normalized name: calcium carbonate 600 mg calcium (1.5 gram) ORAL TABLET,CHEWABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1.5 g/day)
Trial: 3505731
Drug: Midazolam 7.5-15.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 7.5-15.0 mg (mean elimination half-life approximately 2 h)
Trial: 3505731
Drug: Brotizolam 0.125-0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brotizolam 0.125-0.25 mg (mean elimination half-life approximately 5 h)
Trial: 31033786
Drug: Probiotic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic supplementation (Lactobacillus rhamnosus) at a concentration of 5×10^9 CFU per sachet, administered twice daily by mouth.
Trial: 29055531
Drug: Enzyme replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme replacement therapy with agalsidase alfa
Trial: 11878655
Drug: Parenteral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral paracetamol
Trial: 27611038
Drug: Enteral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral paracetamol
Trial: 17081535
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 50 mg from days 5‐9 of the cycle
Trial: 26202922
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clomiphene citrate and metformin
Trial: 15910350
Drug: Levobupivacaine 0.2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine 0.2% (group L)
Trial: 10393047
Drug: Acetazolamide (AZM)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (AZM) 500 mg/d
Trial: 8778430
Drug: 2.51 of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.51 of fluid (1 l normal saline and 1.51 5% dextrose)
Trial: 8778430
Drug: 1 l
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 l of normal saline